I get beat up in The Guardian today a bit with a ham-fisted review. But make no mistake, the book Radicals by journalist and Immortality Bus rider Jamie Bartlett, which is coming out in a few days, is important and brilliant: https://www.theguardian.com/books/2017/may/16/radicals-outsiders-changing-the-world-jamie-bartlett-review #transhumanism
This thoughtful study of radical movements explores politics, sex and drugs.
Men and women differ in obvious and less obvious ways—for example, in the prevalence of certain diseases or reactions to drugs. How are these connected to one’s sex? Weizmann Institute of Science researchers recently uncovered thousands of human genes that are expressed—copied out to make proteins—differently in the two sexes. Their findings showed that harmful mutations in these particular genes tend to accumulate in the population in relatively high frequencies, and the study explains why. The detailed map of these genes, reported in BMC Biology, provides evidence that males and females undergo a sort of separate, but interconnected evolution.
Several years ago, Prof. Shmuel Pietrokovski and Dr. Moran Gershoni of the Weizmann Institute’s Molecular Genetics Department asked why the prevalence of certain human diseases is common. Specifically, about 15% of couples trying to conceive are defined as infertile, which suggested that mutations that impair fertility are relatively widespread. This seems paradoxical: Common sense says that these mutations, which directly affect the survival of the species by reducing the number of offspring, should have been quickly weeded out by natural selection. Pietrokovski and Gershoni showed that mutations in genes specific to sperm formation persist precisely because the genes are expressed only in men. A mutation that is problematic for only half the population, no matter how detrimental, is freely passed on to the next generation by the other half.
In the present study, the researchers expanded their analyses to include genes that, though not necessary for fertility, are still expressed differently in the two sexes. To identify these genes, the scientists turned to the GTEx project—a very large study of human gene expression recorded for numerous organs and tissues in the bodies of close to 550 adult donors. That project enabled, for the first time, the comprehensive mapping of the human sex-differential genetic architecture.
Anyone who watched HBO’s Westworld and came away from it with the desire to have sex with a robot is now in luck. A brothel full of sex dolls has opened up in Barcelona, Spain.
Lumi Dolls offers four models that anyone can reserve for a set amount of time. Thanks to new technology, Lumi Dolls brags that its dolls are among the most realistic on the market — and they cost around €120 per hour, which is about $127. The brothel offers other services as well, including overnight stays and options for couples, but those price quotes require a consultation. Reservations are taken online.
Each of the models come complete with a sort of character page on the Lumi Dolls website, which houses a description of the doll’s anatomy, creative inspiration, and what to look forward to in the doll’s room.
A few stories my futurist work is newly showing up in: http://all.true-news.info/three-innovations-that-will-eventually-replace-sex/ &
https://www.bioedge.org/bioethics/a-quick-look-at-immortality/12195 &
https://technologybux.com/transhumanism-may-become-future-humanity/
In the near future will be a new sexual revolution. According to scientists, there will be innovations that will fundamentally change the idea about sex and its role in society.
Unique contraception
Vasalgel is a contraceptive for men. This drug is administered into human body by injection of the gel. It covers the channels through which the sperm travels to the male sex organ. The effect of the drug can be stopped. You just do one more injection of the substance. It will ruin a gel seminiferous tube threads.
Posted in bioengineering, biotech/medical, business, disruptive technology, DNA, genetics, health, science, sex | Leave a Comment on Bioquark Inc. and SC21 Biotech to Collaborate on Novel Cellular Therapies for Long Term HIV Control
Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm
Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.
“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”
HIV-1 infection afflicts more than 35 million people worldwide. For individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. The only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation from a graft that carried the HIV-resistant CCR5-Delta32 homozygous mutation. The patient has remained without any evidence of HIV infection for more than 8 years after discontinuation of antiretroviral drug therapy.
However, identifying immune matched adult CCR5- Delta32 homozygous donors for a given patients is not readily feasible in part because the prevalence is in only about 0.8%–1% of individuals of northern European descent and much less in other ethnic groups, as well as the fact that for such transplants with adult cells there needs to be a very close HLA match between donor and patient.
In contrast, cord blood that is CCR5- Delta32 homozygous provides a major advantage in that much less stringent HLA matching is required between donor and patient. However, a technological method to cost effectively and industrially scale the production of such cells has been missing.
“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Mr. Paul Collier, Managing Director of SC21 Biotech. “The ability to apply Bioquark’s cellular reprogramming tools in order to produce industrial quantities of such precious cell lines will offer a much greater global penetration of this important therapeutic modality for HIV.”
“Bioquark has spent several years studying the evolutionarily perfected ability of bioactive moieties found in ooplasms to turn back biological time and re-set cellular regulatory state” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This unique initiative is one more step in our broad translation of such natural capabilities to control the progression of human diseases.”
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
About SC21 Biotech
SC21 Biotech is a novel a biotechnology company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.
A story and a question for Valentines — could you fall in love with a robot? Me? the answer is no as I get bored easily and like imagnative conversations; I would get bored after a while of a robot.
Many of us say we have relationships with our dogs, and some—still—with our childhood teddy-bear. Some might claim to have a relationship with their car. And others, although they might not admit it publicly, feel they have some sort of relationship with their sex-doll.
Are all these people deluded? Can we really have relationships with non-human beings?
If so, what about robots? Computerised chat-bots, such as the “personal assistants” Siri (from Apple’s iPhone) and Cortana (from Microsoft), already exist which can remember many of their owner’s likes and dislikes, and respond helpfully to their questions, recognising their individual voice and accent.
There is nothing new about the elusiveness of love.
For millennia, people have written stories, sonnets and songs about the fundamental struggle of finding the perfect mate. Today, technology companies are writing code to help you do just that.
In the Bay Area, innovators like to envision a future in which technology will streamline, simplify and democratize love in its many phases — from dating to sex to marriage and, yes, even heartbreak.
